Neoplasms, Kidney Terminated Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Kidney Neoplasms / Kidney Neoplasm

IndicationStatusPhase
DBCOND0032585 (Neoplasms, Kidney)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00651482Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)Treatment